Plasma and tissue proteomic prognostic factors of response in primary breast cancer patients receiving neoadjuvant chemotherapyJacques Bonneterre(Université Lille Nord de France), Jean-Philippe Peyrat(Centre Oscar Lambret)Oncology ReportsOctober 19, 201210.3892/or.2012.2090Cited by 5SaveCiteExport RISWatch citationsRelated PapersTumour and cellular distribution of activated forms of PR in breast cancers: a novel immunohistochemical analysis of a large clinical cohort|ESMO Open|2016|13